Cargando…
Circulating antibody-secreting cells are a biomarker for early diagnosis in patients with Lyme disease
BACKGROUND: Diagnostic immunoassays for Lyme disease have several limitations including: 1) not all patients seroconvert; 2) seroconversion occurs later than symptom onset; and 3) serum antibody levels remain elevated long after resolution of the infection. INTRODUCTION: MENSA (Medium Enriched for N...
Autores principales: | Haddad, Natalie S., Nozick, Sophia, Ohanian, Shant, Smith, Robert, Elias, Susan, Auwaerter, Paul G., Lee, F. Eun-Hyung, Daiss, John L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624293/ https://www.ncbi.nlm.nih.gov/pubmed/37922270 http://dx.doi.org/10.1371/journal.pone.0293203 |
Ejemplares similares
-
Diagnosis of Streptococcus pneumoniae infection using circulating antibody secreting cells
por: Kyu, Shuya, et al.
Publicado: (2021) -
Editorial Commentary: Life After Lyme Disease
por: Auwaerter, Paul G.
Publicado: (2015) -
Geographic Expansion of Lyme Disease in Michigan, 2000–2014
por: Lantos, Paul M., et al.
Publicado: (2017) -
The antibody response in Lyme disease.
por: Craft, J. E., et al.
Publicado: (1984) -
Comparing the Epidemiology and Health Burden of Lyme Disease and Babesiosis Hospitalizations in the United States
por: Bloch, Evan M, et al.
Publicado: (2022)